Table 2.
Echocardiographic and quality of life outcome differences at 3 months’ follow-up
| CRT group |
Medical therapy group |
P-value for interactiona | |||
|---|---|---|---|---|---|
| IHD | Non-IHD | Non-IHD | IHD | ||
| Mitral regurgitation index, median (IQR) | 16.75 (9.73–26.13) | 13.37 (5.48–24.63) | 19.03 (11.51–31.90) | 18.05 (9.51–28.77) | 0.1866 |
| LVEDD (cm), mean (SD) | 7.15 (0.99) | 6.90 (1.25) | 7.20 (1.11) | 7.26 (1.05) | 0.2858 |
| LVESV (cm3), mean (SD) | 193.99 (69.36) | 194.01 (104.74) | 233.18 (98.36) | 231.54 (86.05) | 0.0354 |
| LVEF (%), mean (SD) | 29.08 (6.90) | 30.59 (8.19) | 26.56 (6.92) | 26.31 (6.50) | 0.3550 |
| IVMD (ms), mean (SD) | 22.38 (20.03) | 32.54 (22.52) | 52.86 (29.24) | 39.30 (27.07) | 0.3570 |
| MLWHF, mean (SD) | 31.29 (19.74) | 41.50 (20.49) | 35.56 (21.68) | 30.25 (22.00) | 0.1542 |
IHD, ischaemic heart disease; IVMD, interventricular mechanical delay; LVEDD, left ventricular end-diastolic diameter; LVESV, left ventricular end-systolic volume.
aBetween effect of treatment and ischaemia.